Osteogenic sarcoma in a child with familial expansile osteolysis syndrome: An accidental association?

Journal of Pediatric Hematology/Oncology

Volumn 32, Issue 2, 2010, Pages e50-e53

  Bacri, Duha ^a   Arush, Myriam Weyl Ben ^a   Vlodavsky, Eugene ^b   Kollander, Yehuda ^d   Militianu, Daniela ^c   Postovsky, Sergey ^a  

^a MEYER CHILDREN S HOSPITAL   (Israel)

^b Rambam Health Care Campus   (Israel)

^c Rambam Health Care Campus ^*  (Israel)

^d TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Alkaline phosphatase; Hyperphosphatasemia; Osteosarcoma

Indexed keywords

CISPLATIN; DOXORUBICIN; IFOSFAMIDE; METHOTREXATE;

ADOLESCENT; ANAMNESIS; ARTICLE; BONE SCINTISCANNING; BONE TURNOVER; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER SURGERY; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DRUG MEGADOSE; FAMILIAL EXPANSILE OSTEOLYSIS SYNDROME; HUMAN; ILIAC BONE; LIFE EXPECTANCY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SKELETON MALFORMATION; TURNOVER TIME;

ADOLESCENT; ALKALINE PHOSPHATASE; BONE NEOPLASMS; BONE REMODELING; HUMANS; MALE; MUTATION; OSTEOLYSIS; OSTEOSARCOMA; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B;

EID: 77949469707     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3181c5ab68     Document Type: Article

References (16)

1. Arndt CA, Crist WM. Common musculoskeletal tumors of childhood and adolescence. N Engl J Med. 1999;341: 342-352.
2. Dahlin DC, Unni KK. Osteosarcoma of bone and its important recognizable varieties. Am J Surg Pathol. 1977;1: 161-172.
3. Tucker MA, D’Angio GI, Boice JD, et al. Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med. 1987;317: 588-593.
4. Savage SA, Burdett L, Troisi R, et al. National osteosarcoma etiology study group. Germ-line genetic variation of TP53 in osteosarcoma. Pediatr Blood Cancer 2007;49: 28-33.
5. Cumin I, Cohen JY, David A, et al. Rothmund-Thomson syndrome and osteosarcoma. Med Pediatr Oncol. 1996;26: 414-416.
6. Rendina D, Gennari L, De Filippo G, et al. Evidence for increased clinical severity of familial and sporadic Paget’s disease of bone in Campania, Southern Italy. J Bone Miner Res. 2006;21: 1828-1835.
7. Whyte MP, Mills BG, Reinus WR, et al. Expansile skeletal hyperphosphatasia: a new familial metabolic bone disease. J Bone Miner Res. 2000;15: 2330-2244.
8. Chong B, Hegde M, Fawkner M, et al. Idiopathic hyperphosphatasia and TNFRSF11B mutations: relationships between phenotype and genotype. J Bone Miner Res. 2003;18: 2095-2104.
9. Osterberg PH, Wallace RG, Adams DA, et al. Familial expansile osteolysis: a new dysplasia. J Bone Joint Surg Br. 1988;70: 255-260.
10. Iancu TC, Almagor G, Friedman E, et al. Chronic familial hyperphosphatasemia. Radiology 1978;129: 669-676.
11. Patel SR. Radiation-induced sarcoma. Curr Treat Options Oncol. 2000;1: 258-261.
12. Nellissery MJ, Padalecki SS, Brkanac Z, et al. Evidence for a novel osteosarcoma tumor-suppressor gene in the chromosome 18 region genetically linked with Paget disease of bone. Am J Hum Genet. 1998;63: 817-824.
13. Hansen MF, Seton M, Merchant A. Osteosarcoma in Paget’s disease of bone. J Bone Miner Res. 2007;21: P58-P63.
14. Hansen MF, Nellissery MJ, Bhattia P. Common mechanisms of osteosarcoma and Paget’s disease. J Bone Miner Res. 1999;14(Suppl 2): 39-44.
15. Sparks AB, Peterson SN, Bell C, et al. Mutation screening of the TNFRSF11A gene encoding receptor activator of NF kappa B (RANK) in familial and sporadic Paget’s disease of bone and osteosarcoma. Calcif Tissue Int. 2001;68: 151-155.
16. McNairn JDK, Damron TA, Landas SK, et al. Inheritance of osteosarcoma and Paget’s disease of bone. J Mol Diag. 2001;3: 171-177.